Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HR-756

Known as: HR 756, HR756 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
1981
Highly Cited
1981
To measure the susceptibility of penicillin-resistant pneumococci to newer beta-lactam agents, we evaluated 54 selected strains… Expand
  • table 1
  • figure 1
1981
1981
Cefodizime (HR221) is a new alpha-methoxyimino cephalosporin developed by Hoechst-Roussel with a reported serum half-life of over… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Highly Cited
1980
Highly Cited
1980
The desacetyl metabolite (DES) of cefotaxime (HR756) is formed in vivo to a significant extent. The in vitro activities of DES… Expand
  • figure 1
  • table 1
1980
1980
Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of… Expand
  • table 1
  • table 2
  • table 3
  • table 4
1980
1980
The in vitro activities of two new beta-lactam antibiotics, moxalactam disodium (LY 127935) and cefotaxime (HR-756), were… Expand
  • table 1
  • table 3
  • table 4
  • table 5
1980
1980
The in vitro antibacterial activity of HR-756 compared to cefoxitin and cefuroxime. 122 multiresistant clinical isolates… Expand
1979
1979
The in vitro activities of LY127935 (LY) were compared with those of other beta-lactam antibiotics. LY was highly active (minimal… Expand
  • table 1
1979
1979
A total of 434 clinical aerobic gram-negative bacillary isolates were tested against LY127935, a new 1-oxa cephalosporin, and… Expand
  • table 1
1979
1979
The activity of cefotaxime (HR756), a new semi-synthetic cephalosporin, was compared with the activity of ampicillin… Expand
Highly Cited
1978
Highly Cited
1978
The in vitro activity of HR756, a new semisynthetic cephalosporin, was compared with the activities of cephalothin, cefoxitin… Expand
  • table 1
  • table 2
  • table 3